“Targeting Metabolic Liver Disorders With Sodium Orthovanadate: A Novel Therapeutic Strategy”. Current Pharmaceutical Research, vol. 1, no. 3, Oct. 2025, pp. 274-8, https://doi.org/10.63785/.